Peder Seglund

Dr. Peder Seglund is a Ph.D. Neuroscientist/Behavioral Psychologist and also holds a degree in Business Management. He has 20+ years of experience in Life Sciences/Contract Research covering multiple therapeutic areas including but not limited to: cancer, diabetes, Parkinson’s, Alzheimer’s, depression, schizophrenia, bipolar, rare diseases and many other therapeutic areas.

Dr. Seglund is an entrepreneurial professional responsible for multi-million dollar revenues with extensive experience in Business Development, Sales Management, Neuroscience, CNS, Microdialysis, Genetics, Genomics, in silico Drug Discovery, in vivo Drug Discovery, Organizational Behavior, Artificial Intelligence AI, Machine Learning ML, Natural Language Processing NLP, Biologics, Biosimilars, Predictive Analysis, Regulatory, Pharmacovigilance, Consulting, Technology, MedTech, Data Science, Clinical Data Management, SaaS, Strategy, Real World Data RWD, Real World Evidence RWE, Health Economics and Outcomes Research HEOR, Generics, Pre-Clinical, and Phase I-IV Clinical Pharmaceutical Research.

He has also published a paper on “Cognitive Deficits and A1C score in Persons with Diabetes” suggesting a correlation between high A1C score and statistically significant cognitive deficits.

Dr. Seglund is married with 4 young boys. He is an avid skier, hunter, boater and outdoorsman.

He leads TruMinds Clinical global Business Development strategy as the premier vendor in clinical trial outsourcing.